SREBF2 and prostate carcinoma: Factors controlling the expression of HMGCR, including SREBP-1a, SREBP-2 and SCAP, were found to be overexpressed in prostate cancer (Krycer et al., 2009), contributing to transcriptional upregulation of HMGCR.